Skip to main content
. 2017 Nov 23;11(4):507–512. doi: 10.1093/ckj/sfx135

Table 3.

Univariate association of patient characteristics and number of medication discrepancies

Number of medication discrepancies
Patient characteristics Zero discrepancies (n = 321) ≥1 discrepancy (n = 392) P-value
Mean number of discrepancies (SD) 0 3.3 (2.8) NA
Mean (±SD) age (years) 68.0 ± 15.8 67.3 ± 16.1 0.40
Gender, n (%) 0.15
 Male 172 (42.7) 231 (57.3)
 Female 149 (48.1) 161 (51.9)
Race, n (%) 0.03
 White 177 (40.8) 257 (59.2)
 Black 89 (51.2) 85 (48.9)
 Other or multiracial 33 (49.3) 34 (50.8)
 Asian 22 (57.9) 16 (42.1)
Hispanic ethnicity, n (%) 0.27
 Yes 33 (51.6) 31 (48.4)
 No 288 (44.4) 361 (55.6)
Hypertension, n (%) 0.01
 Yes 289 (43.7) 373 (56.3)
 No 32 (62.8) 19 (37.2)
Diabetes mellitus, n (%) 0.90
 Yes 163 (44.8) 201 (55.2)
 No 158 (45.3) 191 (54.7)
Congestive heart failure, n (%) 0.0004
 Yes 61 (33.7) 120 (66.3)
 No 260 (48.9) 272 (51.1)
Current smoker, n (%) 0.82
 Yes 20 (48.8) 21 (51.2)
 No 298 (44.7) 368 (55.3)
 Not specified 3 (50.0) 3 (50.0)
Insurance status, n (%) 0.23
 Medicaid 37 (55.2) 30 (44.8)
 Medicare 180 (45.0) 220 (55.0)
 No insurance 4 (57.1) 3 (42.9)
 Private 100 (41.8) 139 (58.2)
Mean (±SD) eGFR (mL/min) 19.1 ± 6.6 18.3 ± 6.2 0.08
Mean (±SD) number of medications 6.8 ± 2.3 9.2 ± 3.8 <0.0001